Vitamin D deficiency and clinical outcome in patients with chronic heart failure: A review

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 27, Issue 10, 2017, Pages 837-849

  D'Amore, C ^a   Marsico, F ^b   Parente, A ^b   Paolillo, S ^c   De Martino, F ^b   Gargiulo, P ^c   Ferrazzano, F ^b   De Roberto, A M ^b   La Mura, L ^b   Marciano, C ^d   Dellegrottaglie, S ^e   Trimarco, B ^b   Perrone Filardi, P ^b  

^a Clinica Mediterranea   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c IRCCS SDN   (Italy)

^d Istituto Diagnostico Varelli   (Italy)

^e Clinica Villa dei Fiori   (Italy)

Author keywords

Cardiovascular outcomes; Heart failure; Vitamin D deficiency; Vitamin D supplementation

Indexed keywords

CALCITRIOL; INTERLEUKIN 10; INTERSTITIAL COLLAGENASE; PARATHYROID HORMONE; STROMELYSIN; TUMOR NECROSIS FACTOR; VITAMIN D RECEPTOR; BIOLOGICAL MARKER; PTH PROTEIN, HUMAN; VITAMIN D;

BLOOD VESSEL CALCIFICATION; BREAST FEEDING; CALCIUM ABSORPTION; CARDIOVASCULAR DISEASE; CLINICAL OUTCOME; HEART FAILURE; HEART INFARCTION; HEART MUSCLE FIBROSIS; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; KIDNEY DISEASE; LEFT VENTRICULAR SYSTOLIC DYSFUNCTION; LIVER FAILURE; MALABSORPTION; OBESITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SMOKING; SUDDEN CARDIAC DEATH; SUN EXPOSURE; VITAMIN D DEFICIENCY; ANIMAL; BLOOD; CHRONIC DISEASE; DIETARY SUPPLEMENT; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE REMODELING; MORTALITY; PREVALENCE; RISK FACTOR; TREATMENT OUTCOME;

ANIMALS; BIOMARKERS; CHRONIC DISEASE; DIETARY SUPPLEMENTS; HEART FAILURE; HUMANS; PARATHYROID HORMONE; PREVALENCE; RISK FACTORS; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 85029764183     PISSN: 09394753     EISSN: 15903729     Source Type: Journal    
DOI: 10.1016/j.numecd.2017.07.009     Document Type: Review

References (56)

1. Jessup, M., Brozena, S., Heart failure. N Engl J Med 348 (2003 May 15), 2007–2018.
2. Bleumink, G.S., Knetsch, A.M., Sturkenboom, M.C., Straus, S.M., Hofman, A., Deckers, J.W., et al. Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure the Rotterdam Study. Eur Heart J 25 (2004), 1614–1619.
3. Levy, D., Kenchaiah, S., Larson, M.G., Benjamin, E.J., Kupka, M.J., Ho, K.K., et al. Long-term trends in the incidence of and survival with heart failure. N Engl J Med 347 (2002), 1397–1402.
4. Rauchhaus, M., Doehner, W., Francis, D.P., Davos, C., Kemp, M., Liebenthal, C., et al. Plasma cytokine parameters and mortality in patients with chronic heart failure. Circulation 102 (2000), 3060–3067.
5. Anderson, J.L., May, H.T., Horne, B.D., Bair, T.L., Hall, N.L., Carlquist, J.F., et al., Intermountain Heart Collaborative (IHC) Study Group. Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population. Am J Cardiol 106 (2010), 963–968.
6. Holick, M.F., Vitamin D deficiency. N Engl J Med 357 (2007), 266–281.
7. Jean, G., Terrat, J.C., Vanel, T., Hurot, J.M., Lorriaux, C., Mayor, B., et al. Evidence for persistent vitamin D 1-alpha-hydroxylation in hemodialysis patients: evolution of serum 1,25-dihydroxycholecalciferol after 6 months of 25-hydroxycholecalciferol treatment. Nephron Clin Pract 110 (2008), c58–65.
8. Souberbielle, J.C., Body, J.J., Lappe, J.M., Plebani, M., Shoenfeld, Y., Wang, T.J., et al. Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: recommendations for clinical practice. Autoimmun Rev 9 (2010), 709–715.
9. Norman, A.W., From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health. Am J Clin Nutr 88 (2008), 491S–499S.
10. Haussler, M.R., Jurutka, P.W., Mizwicki, M., Norman, A.W., Vitamin D receptor (VDR)-mediated actions of 1α,25(OH)₂ vitamin D₃: genomic and non-genomic mechanisms. Best Pract Res Clin Endocrinol Metab 25 (2011), 543–559.
11. Ross, A.C., Manson, J.E., Abrams, S.A., Aloia, J.F., Brannon, P.M., Clinton, S.K., et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 96 (2011), 53–58.
12. Li, Y.C., Kong, J., Wei, M., Chen, Z.F., Liu, S.Q., Cao, L.P., 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 110 (2002), 229–238.
13. Tomaschitz, A., Pilz, S., Ritz, E., Grammer, T., Drechsler, C., Boehm, B.O., et al. Independent association between 1,25-dihydroxyvitamin D, 25-hydroxyvitamin D and the renin-angiotensin system: the Ludwigshafen Risk and Cardiovascular Health (LURIC) Study. Clin Chim Acta 411 (2010), 1354–1360.
14. Forman, J.P., Williams, J.S., Fisher, N.D., Plasma 25-hydroxyvitamin D and regulation of the renin-angiotensin system in humans. Hypertension 55 (2010), 1283–1288.
15. Camici, M., Galetta, F., Franzoni, F., Carpi, A., Zangeneh, F., Vitamin D and heart. Intern Emerg Med 8 (2013), S5–S9.
16. Weber, K.T., Weglicki, W.B., Simpson, R.U., Macro- and micronutrient dyshomeostasis in the adverse structural remodelling of myocardium. Cardiovasc Res 81 (2009), 500–508.
17. Agarwal, M., Phan, A., Willix, R. Jr., Barber, M., Schwarz, E.R., Is vitamin D deficiency associated with heart failure? A review of current evidence. J Cardiovasc Pharmacol Ther 16 (2011), 354–363.
18. Demer, L.L., Tintut, Y., Vascular calcification: pathobiology of a multifaceted disease. Circulation 117 (2008), 2938–2948.
19. Hruska, K.A., Mathew, S., Saab, G., Bone morphogenetic proteins in vascular calcification. Circ Res 97 (2005), 105–114.
20. Watson, K.E., Abrolat, M.L., Malone, L.L., Hoeg, J.M., Doherty, T., Detrano, R., et al. Active serum vitamin D levels are inversely correlated with coronary calcification. Circulation 96 (1997), 1755–1760.
21. Molinari, C., Uberti, F., Grossini, E., Vacca, G., Carda, S., Invernizzi, M., et al. 1α,25-dihydroxycholecalciferol induces nitric oxide production in cultured endothelial cells. Cell Physiol Biochem 27 (2011), 661–668.
22. Cardus, A., Panizo, S., Encinas, M., Dolcet, X., Gallego, C., Aldea, M., et al. 1,25-dihydroxyvitamin D3 regulates VEGF production through a vitamin D response element in the VEGF promoter. Atherosclerosis 204 (2009), 85–89.
23. Grundmann, M., Haidar, M., Placzko, S., Niendorf, R., Darashchonak, N., Hubel, C.A., et al. Vitamin D improves the angiogenic properties of endothelial progenitor cells. Am J Physiol Cell Physiol 303 (2012), C954–C962.
24. Stach, K., Kälsch, A.I., Nguyen, X.D., Elmas, E., Kralev, S., Lang, S., et al. Kälsch T.1α,25-dihydroxyvitamin D3 attenuates platelet activation and the expression of VCAM-1 and MT1-MMP in human endothelial cells. Cardiology 118 (2011), 107–115.
25. Simpson, R.U., Hershey, S.H., Nibbelink, K.A., Characterization of heart size and blood pressure in the vitamin D receptor knockout mouse. J Steroid Biochem Mol Biol 103 (2007), 521–524.
26. Green, J.J., Robinson, D.A., Wilson, G.E., Simpson, R.U., Westfall, M.V., Calcitriol modulation of cardiac contractile performance via protein kinase C. J Mol Cell Cardiol 41 (2006), 350–359.
27. Zitterman, A., Ernst, J.B., Calciotropic and phosphaturic hormones in heart failure. Nutr Metab Cardiovasc Dis 26 (2016), 971–979.
28. Kim, D.H., Sabour, S., Sagar, U.N., Adams, S., Whellan, D.J., Prevalence of hypovitaminosis D in cardiovascular disease (from the National Health and Nutrition Examinantion Survey 2001 to 2004). Am J Cardiol 102 (2008), 1540–1544.
29. DeLuca, H.F., Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr 80 (2004), 1689S–1696S.
30. Kestenbaum, B., Katz, R., de Boer, I., Hoofnagle, A., Sarnak, M.J., Shlipak, M.G., et al. Vitamin D, parathyroid hormone, and cardiovascular events among older adults. J Am Coll Cardiol 58 (2011), 1433–1441.
31. Saleh, F.N., Schirmer, H., Sundsfjord, J., Jorde, R., Parathyroid hormone and left ventricular hypertrophy. Eur Heart J 24 (2003), 2054–2060.
32. Guillot, X., Semerano, L., Saidenberg-Kermanac'h, N., Falgarone, G., Boissier, M.C., Vitamin D and inflammation. Jt Bone Spine 77 (2010), 552–557.
33. Holick, M.F., High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc 81 (2006), 353–373.
34. Shane, E., Mancini, D., Aaronson, K., Silverberg, S.J., Seibel, M.J., Addesso, V., et al. Bone mass, vitamin D deficiency, and hyperparathyroidism in congestive heart failure. Am J Med 103 (1997), 197–207.
35. Zitterman, A., Schleithoff, S.S., Tenderich, G., Berthold, H.K., Korfer, R., Stehle, P., Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure?. J Am Coll Cardiol 41 (2003), 105–112.
36. Pilz, S., März, W., Wellnitz, B., Seelhorst, U., Fahrleitner-Pammer, A., Dimai, H.P., et al. Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiography. J Clin Endocrinol Metab 93 (2008), 3927–3935.
37. Dawson-Hughes, B., Heaney, R.P., Holick, M.F., Lips, P., Meunier, P.J., Vieth, R., Estimates of optimal vitamin D status. Osteoporos Int 16 (2005), 713–716.
38. Wannamethee, S.G., Welsh, P., Papacosta, O., Lennon, L., Whincup, P.H., Sattar, N., Elevated parathyroid hormone, but not vitamin D deficiency, is associated with increased risk of heart failure in older men with and without cardiovascular disease. Circ Heart Fail 7 (2014), 732–739.
39. Bansal, N., Zelnick, L., Robinson-Cohen, C., Hoofnagle, A.N., Ix, J.H., Lima, J.A., et al. Serum parathyroid hormone and 25-hydroxyvitamin D concentration and risk of incident heart failure: th Multi-Ethnic Study of Atherosclerosis. J Am Heart Assoc, 3, 2014, e001278.
40. Chhokar, V.S., Sun, Y., Bhattacharya, S.K., Ahokas, R.A., Myers, L.K., Xing, Z., et al. Hyperparathyroidism and the calcium paradox of aldosteronism. Circulation 111 (2005), 871–878.
41. Liu, L.C., Voors, A.A., van Veldhuisen, D.J., van der Veer, E., Belonje, A.M., Szymanski, M.K., et al. Vitamin D status and outcomes in heart failure patients. Eur J Heart Fail 13 (2011), 619–625.
42. Gotsman, I., Shauer, A., Zwas, D.R., Hellman, Y., Keren, A., Lotan, C., et al. Vitamin D deficiency is a predictor of reduced survival in patients with heart failure; vitamin D supplementation improves outcome. Eur J Heart Fail 14 (2012), 357–366.
43. Gruson, D., Ferracin, B., Ahn, S.A., Zierold, C., Blocki, F., Hawkins, D.M., et al. 1,25-Dihydroxyvitamin D to PTH(1-84) ratios strongly predict cardiovascular death in heart failure. PLoS One, 10, 2015, e0135427.
44. Donneyong, M.M., Hornung, C.A., Taylor, K.C., Baumgartner, R.N., Myers, J.A., Eaton, C.B., et al. Risk of heart failure among postmenopausal women: a secondary analysis of the randomized trial of vitamin D plus calcium of the women's health initiative. Circ Heart Fail 8 (2015), 49–56.
45. Scragg, R., Stewart, A.W., Waayer, D., Lawes, C.M., Toop, L., Sluyter, J., et al. Effect of monthly high-dose vitamin D supplementation on cardiovascular disease in the vitamin D assessment study: a randomized clinical trial. JAMA Cardiol, 2017 Apr 5, 10.1001/jamacardio.2017.0175 [Epub ahead of print].
46. Amin, A., Minaee, S., Chitsazan, M., Naderi, N., Taghavi, S., Ardeshiri, M., Can vitamin D supplementation improve the severity of congestive heart failure?. Congest Heart Fail 19 (2013), E22–E28.
47. Schleithoff, S.S., Zittermann, A., Tenderich, G., Berthold, H.K., Stehle, P., Koerfer, R., Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr 83 (2006), 754–759.
48. Witham, M.D., Crighton, L.J., Gillespie, N.D., Struthers, A.D., McMurdo, M.E., The effects of vitamin D supplementation on physical function and quality of life in older patients with heart failure: a randomized controlled trial. Circ Heart Fail 3 (2010), 195–201.
49. Shedeed, S.A., Vitamin D supplementation in infants with chronic congestive heart failure. Pediatr Cardiol 33 (2012), 713–719.
50. Boxer, R.S., Kenny, A.M., Schmotzer, B.J., Vest, M., Fiutem, J.J., Piña, I.L., A randomized controlled trial of high dose vitamin D3 in patients with heart failure. JACC Heart Fail 1 (2013), 84–90.
51. Boxer, R.S., Hoit, B.D., Schmotzer, B.J., Stefano, G.T., Gomes, A., Negrea, L., The effect of vitamin d on aldosterone and health status in patients with heart failure. J Card Fail 20 (2014), 334–342.
52. Schroten, N.F., Ruifrok, W.P., Kleijn, L., Dokter, M.M., Silljé, H.H., Lambers Heerspink, H.J., et al. Short-term vitamin D3 supplementation lowers plasma renin activity in patients with stable chronic heart failure: an open-label, blinded end point, randomized prospective trial (VitD-CHF trial). Am Heart J 166 (2013), 357–364.
53. Dalbeni, A., Scaturro, G., Degan, M., Minuz, P., Delva, P., Effects of six months of vitamin D supplementation in patients with heart failure: a randomized double-blind controlled trial. Nutr Metab Cardiovasc Dis 24 (2014), 861–868.
54. Jiang, W.L., Gu, H.B., Zhang, Y.F., Xia, Q.Q., Qi, J., Chen, J.C., Vitamin D supplementation in the treatment of chronic heart failure: a meta-analysis of randomized controlled trials. Clin Cardiol 39 (2016), 56–61.
55. Witte, K.K., Byrom, R., Gierula, J., Paton, M.F., Jamil, H.A., Lowry, J.E., et al. Effects of vitamin D on cardiac function in patients with chronic HF: the Vindicate study. J Am Coll Cardiol 67 (2016), 2593–2603.
56. Zittermann, A., Ernst, J.B., Prokop, S., Fuchs, U., Dreier, J., Kuhn, J., et al. Effect of vitamin D on all-cause mortality in heart failure (EVITA): a 3-year randomized clinical trial with 4000 IU vitamin D daily. Eur Heart J, 2017 May 12, 10.1093/eurheartj/ehx235 [Epub ahead of print].